Popular Articles

Like Burrs On Your Clothes, Molecule-Size Capsules Can Deliver Drugs By Sticking To Targeted Cells
It is now possible to engineer tiny containers the size of a virus to deliver drugs and other materials with almost 100 percent efficiency to targeted cells in the bloodstream.

Successful Disease Management Programs Can Play Role In Health Care Reform
A study of the award-winning Behavioral Pharmacy Management Program (BPM) shows the private-public Medicaid partnership program has helped improve patient care while saving eight states almost $95 million in behavioral health pharmaceutical costs. Lilly funds the program, which is designed and run by research firm Comprehensive NeuroScience, Inc. (CNS) at the sole direction and guidance of state Medicaid departments. The BPM, which has been executed in more than half of the states, has won a variety of national awards, including the Substance Abuse and Mental Health Services Administration Science and Service Award, URAC Silver Award for Best Practices in Consumer Empowerment and Protection, American Psychiatric Association Bronze Achievement Award and Disease Management Association of America Gold Award.
News of the day
Daily Potassium Citrate Wards Off Kidney Stones In Seizure Patients On High-fat Diet
Children on the high-fat ketogenic diet to control epileptic seizures can prevent the excruciatingly painful kidney stones that the diet can sometimes cause if they take a daily supplement of potassium citrate the day they start the diet, according to research from Johns Hopkins Children"s Center.
Nutrition

The European Biotech Industry Applauds UK Efforts To Place Industrial Biotech At The Center Of A Low Carbon Economy

EuropaBio, the European biotech industry association applauds the report "IB 2025: Maximising UK Opportunities from Industrial Biotechnology in a Low Carbon Economy" (1) released today by the UK"s Department for Business Enterprise and Regulatory Reform (BERR). The biotech industry welcomes the report which is completely in line with the EU"s Lead Market Initiative for Biobased Products (2). EuropaBio is also pleased to note that the report also embraces EuropaBio"s policy recommendations (3) developed to help the EU realise the vision of a Knowledge-Based Bio-Economy (KBBE). "A competitive European Knowledge-based Bioeconomy can only be realised when the European Union and the member states put a coherent policy framework in place. What has been done in the UK will motivate industry to continue investment in this emerging and innovative industrial sector" said Dirk Carrez, EuropaBio"s Director, Industrial Biotechnology. Over the last two years the biotech industry has supported the European Commission to work out a set of concrete steps to realise the vision of a Knowledge-Based Bio-Economy (KBBE), where biotechnology"s new, clean, energy-efficient processes and innovative biobased products create a sustainable industrial base to ensure Europe"s future prosperity. EuropaBio"s "Industrial Biotechnology Policy Agenda for Europe" (3) produced an outline of policy recommendations to develop a competitive KBBE in Europe, but recognized that in order for these recommendations to be implemented, political support was needed. "EuropaBio is pleased to note the support these recommendations have received from the UK government" said Willy De Greef, EuropaBio"s Secretary General. "Developing an innovation driven economy is at the core of the Lisbon partnership. It is only with support of the member states that the vision to support growth and jobs in Europe by stimulating innovation can be realized." Notes (1) IB 2025: Maximising UK Opportunities from Industrial Biotechnology in a Low Carbon Economy See here. (2) The Commission Website on the Lead Market Initiative (3) Industrial Biotechnology Policy Agenda for Europe EuropaBio


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):